107 related articles for article (PubMed ID: 3481749)
21. Molecular analysis of both translocation products of a Philadelphia-positive CML patient.
de Klein A; van Agthoven T; Groffen C; Heisterkamp N; Groffen J; Grosveld G
Nucleic Acids Res; 1986 Sep; 14(17):7071-82. PubMed ID: 3463934
[TBL] [Abstract][Full Text] [Related]
22. Further evidence for the molecular heterogeneity of chronic myeloid leukemia.
Hernandez A; Corral L; Muñiz A; Alaez C; Espinosa E; Martinez G; Hernandez P
Ann Hematol; 1991 Jun; 62(6):217-20. PubMed ID: 1854884
[TBL] [Abstract][Full Text] [Related]
23. Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome.
Druker BJ; Sawyers CL; Kantarjian H; Resta DJ; Reese SF; Ford JM; Capdeville R; Talpaz M
N Engl J Med; 2001 Apr; 344(14):1038-42. PubMed ID: 11287973
[TBL] [Abstract][Full Text] [Related]
24. Translocation of c-abl to "masked" Ph in chronic myeloid leukemia.
Hagemeijer A; de Klein A; Gödde-Salz E; Turc-Carel C; Smit EM; van Agthoven AJ; Grosveld GC
Cancer Genet Cytogenet; 1985 Oct; 18(2):95-104. PubMed ID: 3863697
[TBL] [Abstract][Full Text] [Related]
25. Immunoglobulin and T cell receptor gene rearrangements in Philadelphia chromosome-positive leukemia: a different involvement pattern in blast crisis and acute leukemia.
Ohyashiki JH; Ohyashiki K; Tauchi T; Saito M; Nakazawa S; Kimura N; Toyama K
Leukemia; 1990 Aug; 4(8):572-9. PubMed ID: 2143795
[TBL] [Abstract][Full Text] [Related]
26. [Deletion (7)(p11p15): an infrequent abnormality in blast crisis in chronic myeloid leukemia].
Resino M; Ferro MT; García-Laraña J; García-Sagredo JM; Cabello P; López-Yarto A; San Román C
Sangre (Barc); 1994 Dec; 39(6):465-7. PubMed ID: 7855700
[TBL] [Abstract][Full Text] [Related]
27. Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.
Hermans A; Heisterkamp N; von Linden M; van Baal S; Meijer D; van der Plas D; Wiedemann LM; Groffen J; Bootsma D; Grosveld G
Cell; 1987 Oct; 51(1):33-40. PubMed ID: 2820585
[TBL] [Abstract][Full Text] [Related]
28. Southern blot analysis of Bcr, N-ras, H-ras, c-myc and myb proto-oncogenes in blast crisis of chronic myelogenous leukemia.
Naoe T; Doi S; Yamanaka K; Naito K; Nitta M; Yamada K
Nihon Ketsueki Gakkai Zasshi; 1989 Feb; 52(1):32-7. PubMed ID: 2741649
[TBL] [Abstract][Full Text] [Related]
29. The variable hematologic expression of the BCR-ABL genomic mutation and its possible determinants.
Fitzgerald PH; Morris CM
Cancer Genet Cytogenet; 1989 Oct; 42(1):9-25. PubMed ID: 2790750
[TBL] [Abstract][Full Text] [Related]
30. Secondary Ph-positive CML with a minority monosomy 7 clone.
Auerbach HE; Stelmach T; LaGuette JG; Glick JH; Kant JA; Nowell PC
Cancer Genet Cytogenet; 1987 Sep; 28(1):173-8. PubMed ID: 3475163
[TBL] [Abstract][Full Text] [Related]
31. The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene.
Ben-Neriah Y; Daley GQ; Mes-Masson AM; Witte ON; Baltimore D
Science; 1986 Jul; 233(4760):212-4. PubMed ID: 3460176
[TBL] [Abstract][Full Text] [Related]
32. Rearrangement of bcr and c-abl sequences in Ph-positive acute leukemias and Ph-negative CML--an update.
Bartram CR
Haematol Blood Transfus; 1987; 31():160-2. PubMed ID: 3481751
[No Abstract] [Full Text] [Related]
33. Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia or Chronic Myeloid Leukemia in Lymphoid Blast Crisis.
Kolenova A; Maloney KW; Hunger SP
J Pediatr Hematol Oncol; 2016 Aug; 38(6):e193-5. PubMed ID: 27164534
[TBL] [Abstract][Full Text] [Related]
34. Clonal succession and deletion of bcr/abl sequences in chronic myelogenous leukemia with recurrent lymphoid blast crisis.
Laneuville P; Sullivan AK
Leukemia; 1991 Sep; 5(9):752-6. PubMed ID: 1943228
[TBL] [Abstract][Full Text] [Related]
35. [Research advance on molecular genetics of CML blast crisis].
Zhu HQ; Zhang S; Liu XL
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):217-21. PubMed ID: 18315935
[TBL] [Abstract][Full Text] [Related]
36. The molecular biology of chronic myeloid leukaemia.
Melo JV
Leukemia; 1996 May; 10(5):751-6. PubMed ID: 8656667
[TBL] [Abstract][Full Text] [Related]
37. [Oncogenes and malignant hemopathies].
Pogliani EM; Bregani ER; Corneo G
Recenti Prog Med; 1989 Oct; 80(10):526-30. PubMed ID: 2690219
[TBL] [Abstract][Full Text] [Related]
38. Lymphoid blast crisis in a patient with Philadelphia-chromosome-negative chronic myelocytic leukemia.
Takahira H; Shibata K; Hirata J; Umemura T; Nishimura J; Nawata H
Acta Haematol; 1989; 81(3):155-9. PubMed ID: 2496564
[TBL] [Abstract][Full Text] [Related]
39. Blastic phase of Ph1-positive chronic myeloid leukemia and t(3;21).
Aventin A; Mecucci C; van den Berghe H
Blood; 1988 Jul; 72(1):369. PubMed ID: 3164638
[No Abstract] [Full Text] [Related]
40. [Analysis of isodicentric Ph chromosomes in chronic myeloid leukemia blast crisis].
Li Q; Lin X; Lin Y; Yao R; Huang W; Mei H; Gong J; Chen H; Teng N
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2017 Feb; 34(1):85-88. PubMed ID: 28186602
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]